Fairchem Organics stock drops 11% on weak Q2 results

Fairchem Organics' stock plunged by over 11% on November 13, continuing its downward trend for the fifth consecutive day. This steep decline follows the company's recent announcement of disappointing earnings for the quarter ending September 30, 2024. This performance has raised concerns among investors, particularly those involved in share market investment.

Disappointing financial results lead to sharp losses

For Q2FY25, Fairchem Organics reported a significant 61% year-on-year (YoY) drop in consolidated net profit, falling to ₹4.01 crore. The company’s revenue also saw a 9% YoY decline, bringing it down to ₹138 crore. Furthermore, its EBITDA decreased by 48% YoY to ₹8.74 crore, while profit margins narrowed to 6.3%, down from 11.05% in the same quarter last year.

Fairchem Organics, formerly known as Adi Finechem Limited, was taken over by Fairfax India Holdings in 2015. This acquisition marked a strategic shift for the company, which now specialises in refining by-products from oil mills to produce essential components for various industries.

Key products and market positioning

Fairchem stands as India’s sole producer of Dimer acid, a vital component in the production of paints, inks, and industrial chemicals. The company also processes Tocopherol, an ingredient essential in the manufacture of natural Vitamin E. This solidifies its presence in both the industrial and consumer markets.

Sequential losses also reported

On a sequential basis, Fairchem’s financials were even worse. The company saw a 71% drop in net profit, a 16% decline in revenue, and a 60% fall in EBITDA quarter-on-quarter (QoQ). Margins also decreased from 13.2% in the previous quarter to 11.02%.

Share market investment outlook

At 11:14 AM, the company’s shares were trading approximately 11% lower at ₹876.95 on the National Stock Exchange (NSE). Year-to-date, the stock has fallen by around 31%, underperforming the Nifty, which has gained 9%. Over the past 12 months, the stock has dropped 25%, while Nifty saw a 22% increase.

Key takeaways

1. Fairchem Organics’ stock fell over 11% after disappointing earnings.
2. The company reported a 61% YoY decline in net profit and a 9% drop in revenue.
3. On a sequential basis, net profit fell 71%, and EBITDA decreased by 60%.
4. The stock has underperformed both the Nifty and its performance over the past year.
5. The company remains a significant player in the specialty chemicals market in India.